Drug Patent Expirations for September 2015

Drug Patent Expirations for September 2015

Tradename	Applicant	Generic Name	Patent No.
DENAVIR	Denco Asset	penciclovir sodium	5,916,893
DENAVIR	Denco Asset	penciclovir sodium	5,840,763
DEPODUR	Pacira Pharms Inc	morphine sulfate	5,807,572
INTEGRILIN	Schering	eptifibatide	5,807,825
SOMAVERT	Pharmacia And Upjohn	pegvisomant	6,057,292
DIPRIVAN	Fresenius Kabi Usa	propofol	5,908,869*PED
DIPRIVAN	Fresenius Kabi Usa	propofol	5,731,355*PED
DIPRIVAN	Fresenius Kabi Usa	propofol	5,731,356*PED
DIPRIVAN	Fresenius Kabi Usa	propofol	5,714,520*PED
KETEK	Sanofi Aventis Us	telithromycin	D459798
VALCYTE	Hoffmann La Roche	valganciclovir hydrochloride	6,083,953*PED
DEXFERRUM	Luitpold	iron dextran	5,624,668
MYCAMINE	Astellas	micafungin sodium	6,265,536
SYMLIN	Astrazeneca Ab	pramlintide acetate	5,814,600
*Drugs may be covered by multiple patents or regulatory protections. See the DrugPatentWatchdatabase for complete details.